Clinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemia

Clinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemia

Abstract Juvenile myelomonocytic leukemia (JMML) is a rare heterogeneous hematological malignancy of early childhood characterized by causative RAS pathway mutations. Classifying patients with JMML using global DNA methylation profiles is useful for risk stratification. We implemented machine learni...

Full description

Bibliographic Details
Main Authors:	Takahiro Imaizumi, Julia Meyer, Manabu Wakamatsu, Hironobu Kitazawa, Norihiro Murakami, Yusuke Okuno, Taro Yoshida, Daichi Sajiki, Asahito Hama, Seiji Kojima, Yoshiyuki Takahashi, Mignon Loh, Elliot Stieglitz, Hideki Muramatsu
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-08-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-18733-4

Similar Items

Clinical and molecular features of <i>CBL</i>-mutated juvenile myelomonocytic leukemia
by: Taro Yoshida, et al.
Published: (2023-05-01)

Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia
by: Elliot Stieglitz, et al.
Published: (2017-12-01)

Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia.
by: Hirotoshi Sakaguchi, et al.
Published: (2015-01-01)

Hematological abnormalities in Jacobsen syndrome: cytopenia of varying severities and morphological abnormalities in peripheral blood and bone marrow
by: Daiki Yamashita, et al.
Published: (2023-06-01)

Juvenile myelomonocytic leukemia: Molecular pathogenesis informs current approaches to therapy & hematopoietic cell transplantation
by: Mignon Lee-cheun Loh, et al.
Published: (2014-03-01)

Predicting response to immunosuppressive therapy in childhood aplastic anemia
by: Nao Yoshida, et al.
Published: (2011-05-01)

Mutation of SBDS and SH2D1A is not associated with aplastic anemia in Japanese children
by: Yue Wang, et al.
Published: (2007-11-01)

Clinical Impact of Melphalan Pharmacokinetics on Transplantation Outcomes in Children Undergoing Hematopoietic Stem Cell Transplantation
by: Ryo Maemura, et al.
Published: (2022-12-01)

A retrospective analysis of gene fusions and treatment outcomes in pediatric acute megakaryoblastic leukemia without Down syndrome
by: Kyogo Suzuki, et al.
Published: (2024-02-01)

Clinical diagnostic value of telomere length measurement in inherited bone marrow failure syndromes
by: Shunsuke Miwata, et al.
Published: (2021-04-01)

Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia
by: Sarah Abu Kar, et al.
Published: (2013-01-01)

P998: TRETINOIN AND CALCITRIOL ENHANCE TREATMENT REGIMENS FOR JUVENILE MYELOMONOCYTIC LEUKEMIA IN EX VIVO DRUG SENSITIVITY ASSAYS
by: Elliot Stieglitz, et al.
Published: (2023-08-01)

P985: CLL-1 IS AN ADOPTIVE IMMUNOTHERAPY TARGET IN JUVENILE MYELOMONOCYTIC LEUKEMIA
by: Juwita Huebner, et al.
Published: (2023-08-01)

Integrated diagnosis based on transcriptome analysis in suspected pediatric sarcomas
by: Daisuke Ichikawa, et al.
Published: (2021-06-01)

Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia
by: Atsushi Narita, et al.
Published: (2015-12-01)

Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine
by: Asahito Hama, et al.
Published: (2015-11-01)

Integration Mapping of piggyBac-Mediated CD19 Chimeric Antigen Receptor T Cells Analyzed by Novel Tagmentation-Assisted PCR
by: Motoharu Hamada, et al.
Published: (2018-08-01)

Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
by: Charlotte M. Niemeyer, et al.
Published: (2015-01-01)

Molecular and phenotypic diversity of <I>CBL</I>-mutated juvenile myelomonocytic leukemia
by: Anna Hecht, et al.
Published: (2020-12-01)

Risk factors of bloodstream infection after allogeneic hematopoietic cell transplantation in children/adolescent and young adults.
by: Daichi Sajiki, et al.
Published: (2024-01-01)

LNK/<i>SH2B3</i> as a novel driver in juvenile myelomonocytic leukemia
by: Astrid Wintering, et al.
Published: (2023-12-01)

A Japanese retrospective study of non-tuberculous mycobacterial infection in children, adolescents, and young adult patients with hematologic-oncologic diseases
by: Yusuke Tsumura, et al.
Published: (2023-10-01)

Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL
by: Alyssa L. Gagne, et al.
Published: (2018-08-01)

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin for refractory or relapsed neuroblastoma
by: Masayuki Imaya, et al.
Published: (2022-05-01)

Molecular basis of juvenile myelomonocytic leukemia
by: Andrica C.H. de Vries, et al.
Published: (2010-02-01)

Juvenile myelomonocytic leukemia: Rare case
by: Hadi Geylan, et al.
Published: (2018-07-01)

Chronic Myelomonocytic Leukemia: Hematopathology Perspective
by: Siba El Hussein, et al.
Published: (2021-08-01)

Lysozyme nephropathy in chronic myelomonocytic leukemia
by: Ami B. Patel, et al.
Published: (2019-06-01)

Chronic Myelomonocytic Leukemia Gold Jubilee
by: Eric Solary, et al.
Published: (2021-07-01)

Aberrant myelomonocytic CD56 expression predicts response to cyclosporine therapy in pediatric patients with moderate aplastic anemia
by: Shanshan Qi, et al.
Published: (2023-12-01)

Ureteral dilatation detected in magnetic resonance imaging predicts vesicoureteral reflux in children with urinary tract infection.
by: Norihiro Murakami, et al.
Published: (2018-01-01)

GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies
by: Xinan Wang, et al.
Published: (2015-10-01)

Phenotypic and genotypic characterisation of juvenile myelomonocytic leukaemia
by: Louka, E
Published: (2018)

Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
by: Xiaoling Liu, et al.
Published: (2012-01-01)

The role of splenectomy in children with juvenile myelomonocytic leukemia
by: Emel Ozyürek, et al.
Published: (2007-04-01)

Acute Myelomonocytic Leukemia Presenting as Perianal Pain
by: Syma Iqbal, et al.
Published: (2018-01-01)

Chronic myelomonocytic leukemia in the light of the WHO proposals
by: Ulrich Germing, et al.
Published: (2007-07-01)

Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia
by: Allan Beke, et al.
Published: (2020-01-01)

Endogenous and combination retinoids are active in myelomonocytic leukemias
by: Orsola di Martino, et al.
Published: (2021-02-01)

Cytogenetic risk stratification in chronic myelomonocytic leukemia
by: Esperanza Such, et al.
Published: (2011-03-01)